Application and Review Process
Applications to use CCaTS facilities undergo two types of review.
- Operational review. The operational review committee consists of a nurse manager, core lab managers, dietitian, and pharmacy and processing lab supervisor and coordinators. The purpose of the operational review is to determine if CCaTS has the resources needed to support a given protocol. Review by an IRB specialist happens concurrently.
- Human subject protection review. The Mayo Clinic Institutional Review Board (IRB) reviews all human subject research conducted at Mayo Clinic (Arizona, Florida and Rochester campuses) and research conducted at other facilities under the direction of Mayo staff. A guarantee that all human subject research at Mayo will be reviewed by the IRB has been given to the U.S. Department of Health and Human Services (HHS) in a Federalwide Assurance (FWA00005001).
View the process flow for application review (PDF) (must be logged in to the Mayo network)
Frequently asked questions
Where can I find a full list of CCaTS facilities?
Visit the main pages for the Clinical Research and Trials Unit (CRTU) and shared/core laboratories.
Who is eligible to use CCaTS facilities?
The staff, facilities (CRTU, shared/core labs) and resources of CCaTS are available to everyone involved in research at Mayo Clinic.
What is the application process for using CCaTS facilities?
Use the IRB's electronic application system, IRBe, to submit your protocol. Complete the IRBe application forms and submit to the Clinical Research and Trials Unit/Translational Technology Cores (CRTU/TTC), which is listed in the ancillary committee list. These forms include a place to attach items including the protocol abstract, budget, women and minority inclusion statements, consent forms, and statistical approval documentation.
In the IRBe application, how do I apply to use CCaTS facilities?
In the IRBe application, answer "yes" to the question, "Will the CRTU and/or TTC be utilized?" (This is question two in section three). After answering "yes," you will be prompted to complete sections 51-54 of the IRBe application.
How much does it cost to use CCaTS facilities?
Contact the CRTU at 507-538-6400 for information about fees and assistance developing a budget.
Where can I find funding opportunities to support my study?
There are multiple intramural funding opportunities available from CCaTS. More opportunities can be found on the Mayo Clinic Office of Sponsored Projects Administration (OSPA) intranet site (must be logged in to the Mayo network).
How do I obtain statistical support if my department does not have a Ph.D.-level statistician?
Contact the CCaTS Service Center at 507-255-7101 to make an appointment with a consultant in the CCaTS biostatistics, epidemiology and research design (BERD) resource.
What is the review process?
View the process flow for application review (PDF) (must be logged in to the Mayo network).
What is a flowsheet meeting? How do I schedule one?
Flowsheet meetings are held prior to protocol implementation in the CRTU and include the CRTU R.N. coordinator, principal investigator or co-investigators, study coordinator, and other pertinent personnel to discuss the specific needs for implementing the study. They are required for all studies that utilize the CRTU. A flowsheet meeting may be requested after the operational review by completing and submitting this online form or after IRB approval (must be logged in to the Mayo network).
What is a special studies meeting? How do I schedule one?
Special studies meetings are required to arrange services provided for research by the Department of Laboratory Medicine and Pathology (DLMP) (must be logged in to the Mayo network) and/or the Immunochemical Core. A meeting can be requested by visiting the DLMP Special Studies Lab Services intranet site (must be logged in to the Mayo network).
After CCaTS and IRB approval
How do I activate my study?
The principal investigator will receive an email with the subject line, "Your approval is needed for activation of IRB xx-xxxxxx." The email is generated after all sections on the protocol activation status report have been checked and will state that the CRTU has completed preparatory work on the protocol and needs final approval before participants may be scheduled. The principal investigator or a key research team member may review the documents for completeness and accuracy and give approval. To give final approval, follow the link provided in the email.
How do I schedule participants for my study?
To schedule participants, you will need access to the CCaTS scheduling system, which is granted electronically after the study team activates the study.
How do I cite CCaTS in my publications?
Visit Citing CCaTS in Publications.